Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy

BACKGROUND: The majority of patients with idiopathic pulmonary arterial hypertension (IPAH) in functional classes II and III are currently being treated with non-parenteral therapies, including endothelin receptor antagonists (ERA), phosphodiesterase (PDE)-5 inhibitors, inhaled iloprost or combinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Knudsen, Lars, Schurawlew, Alexander, Nickel, Nils, Tiede, Henning, Ghofrani, Hossein A, Wilkens, Heinrike, Ewert, Ralf, Halank, Michael, Klose, Hans, Bäzner, Carlos, Behr, Jürgen, Hoeper, Marius M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247176/
https://www.ncbi.nlm.nih.gov/pubmed/22133492
http://dx.doi.org/10.1186/1471-2466-11-56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247176/
https://www.ncbi.nlm.nih.gov/pubmed/22133492
http://dx.doi.org/10.1186/1471-2466-11-56

Ejemplares similares